In yesterday’s Wall Street session, ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN) shares traded at $0.31, down -13.33% from the previous session.
ASLN stock price is now -31.23% away from the 50-day moving average and -62.26% away from the 200-day moving average. The market capitalization of the company currently stands at $7.06M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $8, Jefferies recently initiated with Buy rating for ASLAN Pharmaceuticals Ltd ADR (NASDAQ: ASLN). On January 14, 2019, H.C. Wainwright reiterated its ‘Buy’ rating on the stock by increasing its target price from $12 to quote $8.50
A total of 3.48% of the company’s stock is owned by insiders.
During the past 12 months, ASLAN Pharmaceuticals Ltd ADR has had a low of $0.34 and a high of $4.23. The fifty day moving average price for ASLN is $0.44906 and a two-hundred day moving average price translates $0.81788 for the stock.
The latest earnings results from ASLAN Pharmaceuticals Ltd ADR (NASDAQ: ASLN) was released for 2024-03-31. The net profit margin was -291.89% and return on equity was -426.64% for ASLN.
